Bionano Genomics, Inc. (BMV:BNGO)

Market Cap	230.89M
Revenue (ttm)	641.29M
Net Income (ttm)	-2.33B
Shares Out	n/a
EPS (ttm)	-1,836.46
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	50
Average Volume	8
Open	78.50
Previous Close	73.00
Day's Range	78.50 - 78.50
52-Week Range	58.00 - 1,200.00
Beta	n/a
RSI	45.61
Earnings Date	May 14, 2025

About Bionano Genomics

Bionano Genomics, Inc. provides genome analysis software that enables genomics labs to analyze and interpret data across a range of platforms to generate informative data visualizations for streamlined and simple reporting of causal variants. The company offers Saphyr, a sample-to-result solution for structural variation analysis by optical genome mapping for genome analysis and understanding of genetic variation and function; Saphyr instrument, a single-molecule imager; Saphyr Chip, a consumable that packages the nanochannel arrays for DNA lin...

• Industry: Surgical and Medical Instruments and Apparatus
• Founded: 2003
• Employees: 100
• Stock Exchange: Mexican Stock Exchange
• Ticker Symbol: BNGO

Financial Performance

In 2024, Bionano Genomics's revenue was $30.78 million, a decrease of -14.79% compared to the previous year's $36.12 million. Losses were -$112.02 million, -51.82% less than in 2023.

Financial numbers in USD